إعلان
إعلان
VYGR
Voyager Therapeutics, Inc. Common Stock
4.03
USDبرعاية
-0.03
-0.86%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.12
+0.09
+2.24%
تقارير أرباح VYGR
النسبة الإيجابية المفاجئة
VYGR تفوق 24 من 40 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$10.70M
/-$0.52
التغير الضمني من Q3 25 (Revenue/ EPS)
-19.93%
/+10.64%
التغير الضمني من Q4 24 (Revenue/ EPS)
+70.45%
/-11.86%
Voyager Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٠ نوفمبر ٢٠٢٥, VYGR reported earnings of -0.47 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 11.45% surprise. Revenue reached 13.37 مليون, compared to an expected 8.02 مليون, with a 66.74% difference. The market reacted with a +0.71% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 المحللين forecast an EPS of -0.52 USD, with revenue projected to reach 10.70 مليون USD, implying an زيادة of 10.64% EPS, and نقصان of -19.93% in Revenue from the last quarter.
الأسئلة الشائعة
What were Voyager Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Voyager Therapeutics, Inc. Common Stock reported EPS of -$0.47, beating estimates by 11.45%, and revenue of $13.37M, 66.74% above expectations.
How did the market react to Voyager Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.71%, changed from $4.23 before the earnings release to $4.26 the day after.
When is Voyager Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Voyager Therapeutics, Inc. Common Stock's next earnings report?
Based on 14
المحللين, Voyager Therapeutics, Inc. Common Stock is expected to report EPS of -$0.52 and revenue of $10.70M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان